Tissue-protective effect of glutamine on hepatic ischemia-reperfusion injury via induction of heme oxygenase-1

Pharmacology

Volumn 91, Issue 1-2, 2013, Pages 59-68

  Zhang, Shi Chen ^a,c   Shi, Qiang ^b   Feng, Ya Ni ^b   Fang, Jun ^a,d  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c KUMAMOTO UNIVERSITY   (Japan)

^d SOJO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Glutamine; Heme oxygenase 1; Ischemia reperfusion injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTAMINE; HEME OXYGENASE 1; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTOPORPHYRIN ZINC; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFERASE; URIDINE; BILIRUBIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IN VIVO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LASER DOPPLER FLOWMETRY; LIVER BLOOD FLOW; LIVER ISCHEMIA; LIVER NECROSIS; LIVER PROTECTION; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; UPREGULATION; WESTERN BLOTTING; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER FUNCTION; LIVER HISTOLOGY; LIVER INJURY; REPERFUSION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHEMOKINE CCL2; GLUTAMINE; HEME OXYGENASE (DECYCLIZING); L-LACTATE DEHYDROGENASE; LIVER; LIVER DISEASES; MALE; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; REPERFUSION INJURY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84869227808     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000343809     Document Type: Article

References (43)

1. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-163.
2. Halliwell B, Gutteridge JM: Free radicals, lipid peroxidation, and cell damage. Lancet 1984;ii:1095.
3. McCord JM: The evolution of free radicals and oxidative stress. Am J Med 2000;108:652-659.
4. Maeda H, Akaike T: Oxygen free radicals as pathogenic molecules in viral diseases. Proc Soc Exp Biol Med 1991;198:721-727.
5. Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, Maeda H: Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 1989;244:974-976.
6. Muzykantov VR, Atochina EN, Ischiropou-los H, Danilov SM, Fisher AB: Immunotar-geting of antioxidant enzyme to the pulmonary endothelium. Proc Natl Acad Sci USA 1996;93:5213-5218.
7. Fang J, Seki T, Maeda H: Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev 2009;61:290-302.
8. Miyamoto Y, Akaike T, Yoshida M, Goto S, Horie H, Maeda H: Potentiation of nitric oxide-mediated vasorelaxation by xanthine ox-idase inhibitors. Proc Soc Exp Biol Med 1996;211:366-373.
9. Fa ng J, Iyer AK, Seki T, Na kamura H, Greish K, Maeda H: SMA-copolymer conjugate of AHPP: a polymeric inhibitor of xanthine ox-idase with potential antihypertensive effect. J Control Release 2009;135:211-217.
10. Fang J, Seki T, Qin H, Bharate GY, Iyer AK, Maeda H: Tissue protective effect of xan-thine oxidase inhibitor, polymer conjugate of styrene-maleic acid copolymer and [4-amino-6-hydroxypyrazolo(3, 4-d)pyrim-idine], on hepatic ischemia-reperfusion injury. Exp Biol Med 2010;235:487-496.
11. Maines MD: Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988;2:2557-2568.
12. Fang J, Akaike T, Maeda H: Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in a ntic a ncer treatment. Apoptosis 2004;9:27-35.
13. Attuwaybi BO, Kozar RA, Moore-Olufemi SD, Sato N, Hassoun HT, Weisbrodt NW, Moore FA: Heme oxygenase-1 induction by hemin protects against gut ischemia/reper-fusion injury. J Surg Res 2004;118:53-57.
14. Wischmeyer PE: Glutamine: mode of action in critical illness. Crit Care Med 2007;35: 541-544.
15. Coëffier M, Le Pessot F, Leplingard A, Marion R, Lerebours E, Ducrotté P, Déchelotte P: Acute enteral glutamine infusion enhances heme oxygenase-1 expression in human duodenal mucosa. J Nutr 2002;132:2570-2573.
16. Wischmeyer PE: Glutamine: the first clinically relevant pharmacological regulator of heat shock protein expression? Curr Opin Clin Nutr Metab Care 2006;9:201-206.
17. Umeda K, Takahashi T, Inoue K, Shimizu H, Maeda S, Morimatsu H, Omori E, Akagi R, Katayama H, Morita K: Prevention of hem-orrhagic shock-induced intestinal tissue injury by glutamine via heme oxygenase-1 induction. Shock 2009;31:40-49.
18. Wischmeyer PE, Jayakar D, Williams U, Singleton KD, Riehm J, Bacha EA, Jeevanandam V, Christians U, Serkova N: Single dose of glu-tamine enhances myocardial tissue metabolism, glutathione content, and improves myo-cardial function after ischemia-reperfusion injury. J Parenter Enteral Nutr 2003;27:396-403.
19. Shi Q, Feng YN, Fang J, Xu K: Pretreatment with glutamine attenuates anoxia/reoxygen-ation injury of human proximal renal tubular epithelial cells via induction of heme oxy-genase-1. Pharmacology 2009;84:1-8.
20. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbitu-ric acid reaction. Anal Biochem 1979;95: 351-358.
21. Ikebe N, Akaike T, Miyamoto Y, Hayashida K, Yoshitake J, Ogawa M, Maeda H: Protective effect of S-nitrosylated alpha(1)-protease inhibitor on hepatic ischemia-reperfusion injury. J Pharmacol Exp Ther 2000;295:904-911.
22. Melgarejo E, Medina MA, Sánchez-Jiménez F, Urdiales JL: Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 2009;41: 998-1001.
23. Baranano DE, Rao M, Ferris CD, Snyder SH: Biliverdin reductase: a major physiologic cy-toprotectant. Proc Natl Acad Sci USA 2002; 99:16093-16098.
24. Abraham NG, Kappas A: Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008;60:79-127.
25. Doi K, Akaike T, Fujii S, Tanaka S, Ikebe N, Beppu T, Shibahara S, Ogawa M, Maeda H: Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br J Cancer 1999;80:1945-1954.
26. Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM, Chang EB: Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 2001;90:2403-2410.
27. Wischmeyer PE, Musch MW, Madonna MB, Thisted R, Chang EB: Glutamine protects in-test inal epit hel ia l cel ls: role of i nducible HSP 70. Am J Physiol 1997;272:G879-G884.
28. Sözen S, Kisakürek M, Yildiz F, Gönültas M, Dinçel AS: The effects of glutamine on hepatic ischemia reperfusion injury in rats. Hippokratia 2011;15:161-166.
29. Zhang WX, Zhou LF, Zhang L, Bao L, Wang CC, Meng HY, Yin W: Protective effects of glutamine preconditioning on ischemia-re-perfusion injury in rats. Hepatobiliary Pan-creat Dis Int 2011;10:78-82.
30. Stangl R, Szijártó A, Ónody P, Tamás J, Tátrai M, Hegedus V, Blázovics A, Lotz G, Kiss A, Módis K, Gero D, Szabó C, Kupcsulik P, Harsányi L: Reduction of liver ischemia-re-perfusion injury via glutamine pretreat-ment. J Surg Res 2011;166:95-103.
31. Ziegler TR, Ogden LG, Singleton KD, Luo M, Fernandez-Estivariz C, Griffith DP, Galloway JR, Wischmeyer PE: Parenteral gluta-mine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med 2005;31:1079-1086.
32. Morrison AL, Dinges M, Singleton KD, Odoms K, Wong HR, Wischmeyer PE: Glu-tamine's protection against cellular injury is dependent on heat shock factor-1. Am J Physiol Cell Physiol 2006;290:C1625-C1632.
33. Akaike T, Sato K, Ijiri S, Miyamoto Y, Kohno M, Ando M, Maeda H: Bactericidal activity of alkyl peroxyl radicals generated by heme-iron-catalyzed decomposition of organic peroxides. Arch Biochem Biophys 1992;294:55-63.
34. Jeney V, Balla J, Yachie A, Varga Z, Vercellot-ti GM, Eaton JW, Balla G: Pro-oxidant and cytotoxic effects of circulating heme. Blood 2002;100:879-887.
35. Fang J, Qin H, Seki T, Nakamura H, Tsukigawa K, Shin T, Maeda H: Therapeutic potential of pegylated hemin for reactive oxygen species-related diseases via induction of heme oxygenase-1: results from a rat hepatic ischemia/reperfusion injury model. J Pharmacol Exp Ther 2011;339:779-789.
36. Fang J, Qin H, Nakamura H, Tsukigawa K, Shin T, Maeda H: Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention effect in solid tumors. Cancer Sci 2012;103:535-541.
37. Wei Y, Chen P, de Bruyn M, Zhang W, Bremer E, Helfrich W: Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats. BMC Gastroenterol 2010;10:42.
38. Morrison AL, Dinges M, Singleton KD, Odoms K, Wong HR, Wischmeyer PE: Glu-tamine's protection against cellular injury is dependent on heat shock factor-1. Am J Physiol Cell Physiol 2006;290:C1625-C1632.
39. Torres M: Mitogen-activated protein kinase pathways in redox signaling. Front Biosci 2003;8:d369-d391.
40. Zhang X, Bedard EL, Potter R, Zhong R, Alam J, Choi AM, Lee PJ: Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury. Am J Physiol Lung Cell Mol Physiol 2002;283:L815-L829.
41. Park KM, Chen A, Bonventre JV: Prevention of kidney ischemia/reperfusion- induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pre-treatment. J Biol Chem 2001;276:11870-11876.
42. Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, Southard DJ, Katori M, Volk HD, Bu-suttil RW, Buelow R, Kupiec-Weglinski JW: Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatol-ogy 2002;35:815-823.
43. Omata J, Fukatsu K, Ueno C, Maeshima Y, Saitoh D, Mochizuki H: Intraluminal gluta-mine administration during ischemia worsens survival after gut ischemia-reperfusion. J Surg Res 2007;143:260-264.